We would like to take the opportunity of the upcoming EAU annual meeting to introduce our new test - Bladder EpiCheck, a urine test for the detection and monitoring of bladder cancer.
We will exhibit in booth G64.
Bladder EpiCheck is an objective, operator-independent urine test that provides a positive/negative result and a quantitative score that offers additional clinical tools for the physician1 with better performance than any other non-invasive test.
The test is comprised of 15 different methylation biomarkers that are multiplexed to achieve superior performance. Come to our booth to learn more.
And one last thing – we are conducting an iPad Pro draw in our booth – another reason to stop by.
Hoping to see you at the EAU meeting!
Elon Ganor, MD
Chairman & CEO
Sede del Convegno:
ICM – Internationales Congress Center München
Per maggiori informazioni:
Per scaricare la brochure del nuovo Bladder EpiCheck clicca qui